Seroatlas · Human Serome Atlas

RANBP17

Ran-binding protein 17

Also known as: RBP17_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9H2T7
Gene
RANBP17
Ensembl
ENSG00000204764
Chromosome
5
Canonical length
1088 aa
Protein class
Predicted intracellular proteins, Predicted membrane proteins, Transporters
Subcellular location
Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol

OverviewNCBI Gene

The transport of protein and large RNAs through the nuclear pore complexes (NPC) is an energy-dependent and regulated process. The import of proteins with a nuclear localization signal (NLS) is accomplished by recognition of one or more clusters of basic amino acids by the importin-alpha/beta complex; see MIM 600685 and MIM 602738. The small GTPase RAN (MIM 601179) plays a key role in NLS-dependent protein import. RAN-binding protein-17 is a member of the importin-beta superfamily of nuclear transport receptors.[supplied by OMIM, Jul 2002]

Canonical amino-acid sequenceUniProt

1088 residues, UniProt reviewed canonical sequence.

>Q9H2T7|RANBP17
     1  MALHFQSLAE LEVLCTHLYI GTDLTQRIEA EKALLELIDS PECLSKCQLL LEQGTTSYAQ
    61  LLAATCLSKL VSRVSPLPVE QRMDIRNYIL NYVASQPKLA PFVIQALIQV IAKITKLGWF
   121  EVQKDQFVFR EIIADVKKFL QGTVEHCIIG VIILSELTQE MNLVDYSRPS AKHRKIATSF
   181  RDTSLKDVLV LACSLLKEVF AKPLNLQDQC QQNLVMQVLK LVLNCLNFDF IGSSADESAD
   241  DLCTVQIPTT WRTIFLEPET LDLFFNLYHS LPPLLSQLAL SCLVQFASTR RSLFNSPERA
   301  KYLGNLIKGV KRILENPQGL SDPGNYHEFC RFLARLKTNY QLGELVMVKE YPEVIRLIAN
   361  FTITSLQHWE FAPNSVHYLL TLWQRMVASV PFVKSTEPHL LDTYAPEITK AFITSRLDSV
   421  AIVVRDHLDD PLDDTATVFQ QLEQLCTVSR CEYEKTCALL VQLFDQNAQN YQKLLHPYSG
   481  VTVDITIQEG RLAWLVYLVG TVVGGRLTYT STDEHDAMDG ELSCRVFQLI SLMDTGLPRC
   541  CNEKIELAIL WFLDQFRKTY VGDQLQRTSK VYARMSEVLG ITDDNHVLET FMTKIVTNLK
   601  YWGRYEPVIS RTLQFLNDLS VGYILLKKLV KIDAVKFMLK NHTSEHFPFL GISDNHSLSD
   661  FRCRTTFYTA LTRLLMVDLG EDEDEFENFM LPLTVAFETV LQIFNNNFKQ EDVKRMLIGL
   721  ARDLRGIAFA LNTKTSYTML FDWMYPTYLP LLQNAVERWY GEPTCTTPIL KLMAELMQNR
   781  SQRLNFDVSS PNGILLFREA SKMVCTYGNQ ILSLGSLSKD QIYPMKLKGI SICYSALKSA
   841  LCGNYVSFGV FKLYGDNHFD NVLQAFVKML LSVSHSDLLQ YRKLSQSYYP LLECLTQDHM
   901  SFIINLEPPV LMYVLTSISE GLTTLDTVVS SSCCTSLDYI VTYLFKHIAK EGKKPLRCRE
   961  ATQAGQRLLH FMQQNPDVLQ QMMSVLMNTI VFEDCRNQWS VSRPLLGLIL LNEKYFSELR
  1021  ASLINSQPLP KQEVLAQCFR NLMEGVEQNL SVKNRDRFTQ NLSVFRRDVA EALRSDGNTE
  1081  PCSLDMMS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RANBP17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.24
Highest tissue expression
1.3 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 1.3 nTPM
  • testis: 1.3 nTPM
  • thyroid gland: 1 nTPM
  • salivary gland: 0.9 nTPM
  • adrenal gland: 0.8 nTPM
  • retina: 0.8 nTPM

Single-cell type

  • alveolar cells type 1: 545 nCPM
  • choroid plexus epithelial cells: 469 nCPM
  • adrenal cortex cells: 343 nCPM
  • undifferentiated spermatogonia: 331 nCPM
  • endometrial luminal cells: 330 nCPM
  • transitional alveolar cells: 311 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • cerebellum: 5.4 nTPM
  • pons: 3.3 nTPM
  • hypothalamus: 2.7 nTPM
  • white matter: 2.7 nTPM
  • medulla oblongata: 2.4 nTPM
  • choroid plexus: 2.2 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.32
gnomAD pLI
0
gnomAD missense Z
-1.11
DepMap mean gene effect
0.13
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RANBP17 as an antibody target. Whether an autoantibody or antibody against RANBP17 could matter depends on whether native RANBP17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RANBP17 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RANBP17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RANBP17. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...